Molecular Formula | C9H17NO2.C2HF3O2 |
Molar Mass | 285.26 |
Melting Point | 120 - 123° C |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | White to Off-White |
Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
Stability | Hygroscopic |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.506 ml | 17.528 ml | 35.056 ml |
5 mM | 0.701 ml | 3.506 ml | 7.011 ml |
10 mM | 0.351 ml | 1.753 ml | 3.506 ml |
5 mM | 0.07 ml | 0.351 ml | 0.701 ml |
Use | PR171 intermediate (trifluoroacetate) is an intermediate of carfilzomib (C183460), which is a second-generation proteasome inhibitor, It is used as a treatment in relapsed and refractory multiple myeloma. PR171 intermediates (trifluoroacetate) are organic synthesis intermediates and pharmaceutical intermediates, which can be used in laboratory research and development processes and chemical and pharmaceutical synthesis processes. |